Who is sponsoring NCT03404297?

NCT03404297 is sponsored by Indiana University.

What drugs are being tested in NCT03404297?

Interventions in NCT03404297: Locally sourced compression therapy.

What condition does NCT03404297 study?

NCT03404297 studies Chronic Leg Ulcer, Kaposi Sarcoma, HIV/AIDS and Infections.

Is NCT03404297 still recruiting?

NCT03404297 is currently completed. Last updated 28 September 2023.

Last reviewed 2023-09-28 · How we verify

NCT03404297

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya

Completed NA Last updated 28 September 2023

What this trial tests

NA trial testing Locally sourced compression therapy in Chronic Leg Ulcer in 30 participants. Completed in 31 December 2019.

Timeline

1 March 2018

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	Indiana University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 March 2018
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	2 locations across Kenya

Drugs / interventions tested

Locally sourced compression therapy

Conditions studied

Chronic Leg Ulcer — all drugs for Chronic Leg Ulcer →
Kaposi Sarcoma — all drugs for Kaposi Sarcoma →
HIV/AIDS and Infections — all drugs for HIV/AIDS and Infections →

Sponsor

Indiana University

Who can join

18 and older, any sex, with Chronic Leg Ulcer or Kaposi Sarcoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The efficacy of locally sourced compression therapy in the management of chronic leg ulcers and Kaposi Sarcoma in western Kenya will be studied in a rural setting

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Compression bandages or stockings versus no compression for treating venous leg ulcers.
Shi C, Dumville JC, Cullum N, Connaughton E, et al · · 2021 · cited 39× · PMID 34308565 · DOI 10.1002/14651858.cd013397.pub2
Randomized controlled trial to evaluate locally sourced two-component compression bandages for HIV-associated Kaposi sarcoma leg lymphedema in western Kenya: The Kenyan Improvised Compression for Kaposi Sarcoma (KICKS) study protocol.
Chang AY, Karwa R, Busakhala N, Fletcher SL, et al · · 2018 · cited 4× · PMID 30402565 · DOI 10.1016/j.conctc.2018.10.003
Compression Therapy for HIV-Associated Kaposi Sarcoma Leg Lymphedema: Results of the Kenyan Improvised Compression for Kaposi Sarcoma Randomized Controlled Trial.
Chang AY, Karwa R, Odhiambo H, Were P, et al · · 2022 · cited 3× · PMID 35025687 · DOI 10.1200/go.21.00329

Verify or expand the search:

Other recruiting trials for Chronic Leg Ulcer

Currently open trials in the same condition.

NCT07294521 — Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers · EARLY_PHASE1 · recruiting
NCT05422248 — Oxygen Wound Therapy Feasibility Study · NA · recruiting

Other Indiana University trials

Trials by the same sponsor.

NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03404297 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indiana University
Last refreshed: 28 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03404297.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing